| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Galectin-9 | Human Galectin-9 / LGALS9 Protein, Tag Free (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $515.00 100ug | |||
| Galectin-9 | Human Galectin-9 / LGALS9 Protein, His Tag, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $315.00 50ug | |||
| Galectin-9 | Avitag LG9-H82H3 | Biotinylated Human Galectin-9 / LGALS9 Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| LYT-200 | LYT-200 | Phase 2 Clinical | Puretech Health | Carcinoma, Transitional Cell; Cholangiocarcinoma; Colorectal Neoplasms; Head and Neck Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasm Metastasis; Pancreatic Neoplasms; Solid tumours | Details |
| Anti-Gal9 antibody (Fibrogen) | FG-3165; HFB-200901; HFB-200902; HFB2009; HFB2009 series; HFB9-2 | Phase 1 Clinical | HiFiBiO Therapeutics | Solid tumours | Details |